For the first time, in vivo DMLC tracking has been demonstrated on a linear accelerator showing the potential for improved targeting accuracy.
The study mimicked the envisioned patient workflow of future patient treatments.
Clinical implementation of MV image-based tracking would require markers designed for MV visibility.
2012-01-16
Eng.
Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. perpolse [at] rm.dk
Int J Radiat Oncol Biol Phys. 2012 Feb;82(2):e321-7
© Galenicom 1999-2013